mepolizumab
Showing 1 - 25 of 44
Asthma Trial (Mepolizumab, Spirometry)
Not yet recruiting
- Asthma
- Mepolizumab
- Spirometry
- (no location specified)
Sep 15, 2023
Rhinosinusitis Chronic, Polyp, Nasal Trial in Spain (Mepolizumab, Polypeptomy)
Not yet recruiting
- Rhinosinusitis Chronic
- Polyp, Nasal
- Mepolizumab
- Polypeptomy
-
Bilbao, Spain
- +6 more
Jun 19, 2023
Asthma, Aspirin-Induced, Chronic Rhinosinusitis With Nasal Polyps Trial in Helsinki (Mepolizumab, Placebo)
Recruiting
- Asthma, Aspirin-Induced
- Chronic Rhinosinusitis With Nasal Polyps
- Mepolizumab
- Placebo
-
Helsinki, FinlandHelsinki University Hospital
Aug 5, 2022
Children & Severe Asthma WithEosinophilic Phenotype Treated With
Recruiting
- Asthma in Children
- Mepolizumab
-
London, United KingdomKing's College Hospital
Aug 17, 2022
Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma:
Recruiting
- Asthma
- Mepolizumab
- Standard inhaled corticosteroids (ICS) and long-acting beta 2 agonists (LABA)
-
Lund, Skane, SwedenThe Lung and Allergy Clinic, Skåne University Hospital (SUS)
Jan 16, 2023
Eosinophilic Granulomatosis With Polyangiitis Trial in Tulsa, Norfolk (Depemokimab, Mepolizumab, Placebo matching mepolizumab)
Not yet recruiting
- Eosinophilic Granulomatosis With Polyangiitis
- Depemokimab
- +3 more
-
Tulsa, Oklahoma
- +1 more
Jul 19, 2022
Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis) Trial (Mepolizumab)
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Chronic Rhinosinusitis (Diagnosis)
- Mepolizumab
- (no location specified)
May 30, 2023
Eosinophilic Fasciitis Trial (Mepolizumab)
Not yet recruiting
- Eosinophilic Fasciitis
- Mepolizumab
- (no location specified)
Jan 19, 2022
COPD, Eosinophilia Trial in Leicester (Mepolizumab, Placebo)
Recruiting
- COPD
- Eosinophilia
- Mepolizumab
- Placebo
-
Leicester, Leicestershire, United KingdomNIHR Biomedical Research Centre, Respiratory
Jan 28, 2022
Nation-wide Health Resource Consumption and Costs Associated
Recruiting
- Asthma
- Mepolizumab
-
Montpellier, FranceUh Montpellier
Dec 13, 2021
Chronic Rhinosinusitis With Nasal Polyps Trial in Vancouver (Mepolizumab)
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Mepolizumab
-
Vancouver, British Columbia, CanadaSt. Paul's Sinus Centre
Oct 24, 2023
Chronic Cough, Eosinophilic Bronchitis, Asthma Trial in Hamilton (Mepolizumab, Normal Saline)
Recruiting
- Chronic Cough
- +2 more
- Mepolizumab
- Normal Saline
-
Hamilton, Ontario, CanadaMcMaster University
Dec 16, 2021
Mepolizumab on Severe Refractory Eosinophilic Asthma With or
Recruiting
- Asthma
- +2 more
- Mepolizumab
-
Telese Terme, BN, ItalyIstituti Clinici Scientifici Maugeri IRCCS
Dec 20, 2021
Hypereosinophilic Syndrome Trial in Argentina, Spain, United States (Mepolizumab)
Recruiting
- Hypereosinophilic Syndrome
- Mepolizumab
-
Rochester, Minnesota
- +8 more
Aug 11, 2022
Asthma Trial in India (Prednisone/ Prednisolone, Mepolizumab, Salbutamol)
Recruiting
- Asthma
- Prednisone/ Prednisolone
- +2 more
-
Bangalore, Karnataka, India
- +10 more
Feb 7, 2022
Nasal Polyps Trial in China, Japan, Russian Federation (Mepolizumab, Placebo, Standard of care)
Active, not recruiting
- Nasal Polyps
- Mepolizumab
- +2 more
-
Dongguan, Guangdong, China
- +60 more
Jan 10, 2023
Residual Exacerbations With Mepolizumab
Not yet recruiting
- Asthma
- Mepolizumab
- (no location specified)
Feb 17, 2021
Hypereosinophilic Syndrome Trial (Mepolizumab)
No longer available
- Hypereosinophilic Syndrome
- Mepolizumab
- (no location specified)
Nov 23, 2020
Asthma, Eosinophilic Asthma Trial in New Lambton (Mepolizumab, Omalizumab)
Unknown status
- Asthma
- Eosinophilic Asthma
- Mepolizumab
- Omalizumab
-
New Lambton, New South Wales, AustraliaJohn Hunter Hospital
Oct 6, 2020
Churg-Strauss Syndrome Trial in Worldwide (Mepolizumab, Prednisolone)
Active, not recruiting
- Churg-Strauss Syndrome
- Mepolizumab
- Prednisolone
-
Denver, Colorado
- +31 more
Mar 11, 2021
Hypereosinophilic Syndromes, Eosinophilic Gastroenteritis, Churg-Strauss Syndrome Trial in Cincinnati (Mepolizumab)
Completed
- Hypereosinophilic Syndromes
- +3 more
- Mepolizumab
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 27, 2020
Hypereosinophilia, Hypereosinophilic Syndrome Trial in Worldwide (mepolizumab)
Completed
- Hypereosinophilia
- Hypereosinophilic Syndrome
- mepolizumab
-
San Diego, California
- +28 more
May 1, 2020